Events
23rd Annual Biotech in Europe Forum - Sachs Associates
Bioxodes' CEO March Dechamps presents at the 23rd Annual Biotech in Europe Forum for Global Parntering & Investment, organised by Sachs Associates
CEO Marc Dechamps will present groundbreaking developments in Bioxodes' journey towards revolutionizing stroke care.
Our lead candidate Ir-CPI has a distinctive mode of action which provides a dual benefit by preventing blood clots, minimizing bleeding risks, and inhibiting neuroinflammatory events linked to intracerebral hemorrhage.